Cargando…

Compounded medications for ocular surface disease

Detalles Bibliográficos
Autores principales:	Lee, Edward H., Novack, Gary D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Pipeline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760211/ https://www.ncbi.nlm.nih.gov/pubmed/34555526 http://dx.doi.org/10.1016/j.jtos.2021.09.004

Ejemplares similares

Repurposing medications
por: Novack, Gary D.
Publicado: (2021)

What is an adequate and well controlled study?
por: Novack, Gary D.
Publicado: (2021)

Five variables that rule your life – Home mortgage and biostatistical power
por: Novack, Gary D.
Publicado: (2020)

Expedited regulatory product approval in the time of COVID-19
por: Novack, Gary D.
Publicado: (2022)

FDA review times for new drugs in ophthalmology
por: Carpenter, Michelle A., et al.
Publicado: (2020)

Special features of RAD Sequencing data: implications for genotyping
por: Davey, John W, et al.
Publicado: (2013)

Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus
por: Nagy, László, et al.
Publicado: (2014)

Targeting β(3)-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade
por: Cannavo, Alessandro, et al.
Publicado: (2017)

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018)

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
por: Guarracino, Fabio, et al.
Publicado: (2018)

EST Pipeline System: Detailed and Automated EST Data Processing and Mining
por: Xu, Hao, et al.
Publicado: (2003)

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure
por: Wohlford, George F., et al.
Publicado: (2021)

The JCSG high-throughput structural biology pipeline
por: Elsliger, Marc-André, et al.
Publicado: (2010)

TOPSAN: use of a collaborative environment for annotating, analyzing and disseminating data on JCSG and PSI structures
por: Krishna, S. Sri, et al.
Publicado: (2010)

Investigational Anti–Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?
por: Burashnikov, Alexander
Publicado: (2020)

Ocular surface microbiota: Ophthalmic infectious disease and probiotics
por: Chiang, Ming-Cheng, et al.
Publicado: (2022)

Ocular Surface Disease Index and Ocular Thermography in Keratoconus Patients
por: Németh, Orsolya, et al.
Publicado: (2020)

Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
por: Cvenkel, Barbara, et al.
Publicado: (2015)

A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications
por: Zhou, Xiaoyu, et al.
Publicado: (2022)

Various therapies for ocular surface diseases
por: Gheorghe, Alina, et al.
Publicado: (2018)

Ocular Surface Diseases in Patients With Diabetes
por: Naik, Kunj, et al.
Publicado: (2022)

Cataract surgery in ocular surface disease
por: Priyadarshini, K, et al.
Publicado: (2023)

Impact of Exposomes on Ocular Surface Diseases
por: Hong, Merrelynn, et al.
Publicado: (2023)

Interleukin-17 in Various Ocular Surface Inflammatory Diseases
por: Kang, Min Ho, et al.
Publicado: (2011)

Ocular Surface Potential Difference Measured in Human Subjects to Study Ocular Surface Ion Transport
por: Pasricha, Neel D., et al.
Publicado: (2020)

The Ocular Surface and the Coronavirus Disease 2019: Does a Dual ‘Ocular Route’ Exist?
por: Napoli, Pietro Emanuele, et al.
Publicado: (2020)

Ocular surface disease signs and symptoms of glaucoma patients and their relation to glaucoma medication in Finland
por: Parkkari, Minna, et al.
Publicado: (2022)

Clinical associations of corneal neuromas with ocular surface diseases
por: Toh, Charmaine Jan Li, et al.
Publicado: (2023)

Ocular Surface Disease: Advances in Diagnostics and Therapeutics
por: Gatzioufas, Zisis, et al.
Publicado: (2018)

Ocular Examination and Corneal Surface Disease in the Ferret
por: Myrna, Kathern E., et al.
Publicado: (2019)

Commentary: Evaluating ocular surface disease in glaucoma
por: Behera, Geeta, et al.
Publicado: (2022)

Mechanistic investigations of diabetic ocular surface diseases
por: Zhou, Qingjun, et al.
Publicado: (2022)

Contact lenses for the treatment of ocular surface diseases
por: Sah, Ramkishor, et al.
Publicado: (2023)

Role of ocular surface microbiome in health and disease
por: Doularamani, Minal, et al.
Publicado: (2023)

Improvement of chronic corneal opacity in ocular surface disease with prosthetic replacement of the ocular surface ecosystem (PROSE) treatment
por: Cressey, Anna, et al.
Publicado: (2018)

Optimization of the Ocular Surface Through Treatment of Ocular Surface Disease Before Ophthalmic Surgery: A Narrative Review
por: Schechter, Barry, et al.
Publicado: (2022)

Ocular surface tumors
por: Varde, Meghana Anika, et al.
Publicado: (2009)

Ocular surface tumors
por: Othman, Ihab Saad
Publicado: (2009)

Ocular surface leproma
por: Ram, J, et al.
Publicado: (2018)

Tribology and the Ocular Surface
por: Lievens, Chris W, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ku5lv32cke8a5udtse5rd1e0o